Leukemia Clinical Trial
Official title:
Healing Touch as a Supportive Intervention for Adult Acute Leukemia Patients: A Pilot Study
RATIONALE: Supportive care, such as healing touch, may improve quality of life in patients
receiving chemotherapy for acute leukemia.
PURPOSE: This clinical trial is studying how well healing touch works in treating patients
receiving chemotherapy for acute myeloid leukemia or acute lymphocytic leukemia.
OBJECTIVES:
- Determine the feasibility of conducting a randomized controlled trial, in terms of
recruiting and retaining participants, to a study of healing touch (HT) as supportive
care in patients receiving chemotherapy for acute myeloid leukemia or acute
lymphoblastic leukemia.
- Examine potential barriers to participation and ascertain reasons for study drop-outs
in these patients.
- Demonstrate whether these patients will comply with treatment sessions and remain in
the study.
- Obtain preliminary data on the effectiveness of HT on psychological distress and
treatment-related symptoms focusing on fatigue and sleep disturbances in these
patients.
- Determine if the HT protocol needs to be refined, modified, or eliminated, based on
pilot participant feedback, for a randomized clinical trial.
OUTLINE: This is a pilot study.
Within 1 week of admission to the hospital, patients are interviewed by a research assistant
about previous use of complementary or alternative medicine therapies, knowledge of healing
touch (HT), previous experience with HT, willingness to participate in a study of HT for
acute leukemia patients, and willingness to be randomized in a HT study. The first 12
patients interested in undergoing HT undergo a 30-minute session of HT therapy 3 times a
week during weeks 2, 3, and 4 of induction or reinduction chemotherapy. Patients are also
asked to rate current distress, pain, fatigue, and nausea before and after the second HT
session during weeks 2, 3, and 4. Patients also complete self-report questionnaires at
baseline, during week 5 of induction or reinduction chemotherapy or prior to discharge from
the hospital, and during the first week of consolidation chemotherapy (approximately week
9-13).
PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05691608 -
MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2
|
N/A | |
Recruiting |
NCT04092803 -
Virtual Reality as a Distraction Technique for Performing Lumbar Punctures in Children and Young Adu
|
N/A | |
Active, not recruiting |
NCT02530463 -
Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome
|
Phase 2 | |
Completed |
NCT00948064 -
Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
|
Phase 2 | |
Completed |
NCT04474678 -
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")
|
N/A | |
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Recruiting |
NCT03948529 -
RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation
|
Phase 2 | |
Completed |
NCT01682226 -
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
|
Phase 2 | |
Completed |
NCT00003270 -
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
|
Phase 2 | |
Active, not recruiting |
NCT02723994 -
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
|
Phase 2 | |
Terminated |
NCT02469415 -
Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS)
|
Phase 2 | |
Recruiting |
NCT04856215 -
90Y-labelled Anti-CD66 ab in Childhood High Risk Leukaemia
|
Phase 2 | |
Recruiting |
NCT06155188 -
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia
|
N/A | |
Completed |
NCT00001637 -
Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults
|
Phase 2 | |
Active, not recruiting |
NCT04188678 -
Resiliency in Older Adults Undergoing Bone Marrow Transplant
|
N/A | |
Completed |
NCT02910583 -
Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)
|
Phase 2 | |
Completed |
NCT01212926 -
Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D Strain
|
N/A | |
Terminated |
NCT00014560 -
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Recruiting |
NCT04977024 -
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
|
Phase 2 | |
Recruiting |
NCT05866887 -
Insomnia Prevention in Children With Acute Lymphoblastic Leukemia
|
N/A |